Posted: 13 November 2023
Peter Mac will be part of a pioneering initiative driven by Moderna to bring together key Australian medical research institutes to form a mRNA Platform Incubator Network.
The mRNA Platform Incubator Network aims to advance mRNA medicine, foster scientific excellence in clinical translation in Australia and further the therapeutic potential of the mRNA platform.
The Platform Incubator Network brings together Australia’s leading minds in mRNA research from Peter Mac, Monash University and Monash Institute of Pharmaceutical Sciences (MIPS), the Peter Doherty Institute of Infection and Immunity, the Murdoch Research Children’s Institute and Doherty Clinical Trials Limited.
Professor Ricky Johnstone, Executive Director of Cancer Research, said that Peter Mac was delighted to collaborate with Moderna and other leading research institutes to harness the potential of mRNA technology.
Moderna’s Regional Research Centre in Melbourne will serve as a hub for the Platform Incubator Network, enabling regular cross-functional collaboration, exploration and execution of translational research projects.
The collaboration will contribute new insights to the broader scientific and regulatory community through publications and discussions and support the development of the next generation of researchers.
“Moderna is deeply committed to fostering Australia’s mRNA R&D ecosystem. The launch of the mRNA Platform Incubator Network is a testament to this commitment and to Australia as an emerging leader in mRNA research,” said Dr. Craig Rayner, Director of Moderna’s Regional Research Centre for Respiratory Medicines and Tropical Diseases.
